|
| 34042314 | Efficacy, Safety, and Pharmacodynamic Effects of the Bruton's Tyrosine Kinase Inhibitor Fenebrutinib (GDC-0853) in Systemic Lupus Erythematosus: Results of a Phase II, Randomized, Double-Blind, Placebo-Controlled Trial. | Arthritis Rheumatol | 2021 |
| 34750553 | Fenebrutinib in H<sub>1</sub> antihistamine-refractory chronic spontaneous urticaria: a randomized phase 2 trial. | Nat Med | 2021 |
| 31376152 | Complex DDI by Fenebrutinib and the Use of Transporter Endogenous Biomarkers to Elucidate the Mechanism of DDI. | Clin Pharmacol Ther | 2020 |
| 31907670 | Population Pharmacokinetics, Efficacy Exposure-response Analysis, and Model-based Meta-analysis of Fenebrutinib in Subjects with Rheumatoid Arthritis [corrected]. | Pharm Res | 2020 |
| 31980965 | Correction to: Population Pharmacokinetics, Efficacy Exposure-response Analysis, and Model-based Meta-analysis of Fenebrutinib in Subjects with Rheumatoid Arthritis. | Pharm Res | 2020 |
| 33139537 | Antibody-mediated activation of the FGFR1/Klothoβ complex corrects metabolic dysfunction and alters food preference in obese humans. | Proc Natl Acad Sci U S A | 2020 |
| 32383787 | Physiologically-Based Pharmacokinetic Model-Informed Drug Development for Fenebrutinib: Understanding Complex Drug-Drug Interactions. | CPT Pharmacometrics Syst Pharmacol | 2020 |
| 32270926 | Fenebrutinib versus Placebo or Adalimumab in Rheumatoid Arthritis: A Randomized, Double-Blind, Phase II Trial (ANDES Study). | Arthritis Rheumatol | 2020 |
| 32535897 | Understanding the Effect of Hydroxypropyl-β-Cyclodextrin on Fenebrutinib Absorption in an Itraconazole-Fenebrutinib Drug-Drug Interaction Study. | Clin Pharmacol Ther | 2020 |
| 31371481 | Absence of Pharmacokinetic Interactions between the Bruton's Tyrosine Kinase Inhibitor Fenebrutinib and Methotrexate. | J Pharmacol Exp Ther | 2019 |
| 29484638 | Safety, Pharmacokinetics, and Pharmacodynamics in Healthy Volunteers Treated With GDC-0853, a Selective Reversible Bruton's Tyrosine Kinase Inhibitor. | Clin Pharmacol Ther | 2018 |
| 29522347 | In Vitro, in Silico, and in Vivo Assessments of Intestinal Precipitation and Its Impact on Bioavailability of a BCS Class 2 Basic Compound. | Mol Pharm | 2018 |
| 28834434 | Biorelevant Dissolution Models for a Weak Base To Facilitate Formulation Development and Overcome Reduced Bioavailability Caused by Hypochlordyria or Achlorhydria. | Mol Pharm | 2017 |
| 23187863 | An overview of transporter information in package inserts of recently approved new molecular entities. | Pharm Res | 2013 |
| 23982262 | Measuring the overall genetic component of nevirapine pharmacokinetics and the role of selected polymorphisms: towards addressing the missing heritability in pharmacogenetic phenotypes? | Pharmacogenet Genomics | 2013 |
| 20216335 | Very important pharmacogene summary: ABCB1 (MDR1, P-glycoprotein). | Pharmacogenet Genomics | 2011 |
| 21502085 | Genome-wide association study implicates PARD3B-based AIDS restriction. | J Infect Dis | 2011 |
| 20877624 | Genetic variants in nuclear-encoded mitochondrial genes influence AIDS progression. | PLoS One | 2010 |
| 21083371 | Genetic associations of variants in genes encoding HIV-dependency factors required for HIV-1 infection. | J Infect Dis | 2010 |
| 20799350 | Functional hot spots in human ATP-binding cassette transporter nucleotide binding domains. | Protein Sci | 2010 |
| 19295159 | Evolutionary conservation of vertebrate blood-brain barrier chemoprotective mechanisms in Drosophila. | J Neurosci | 2009 |
| 17940136 | The effects of ABCB1 3'-untranslated region variants on mRNA stability. | Drug Metab Dispos | 2008 |
| 19096711 | Steady state bioequivalence of generic and innovator formulations of stavudine, lamivudine, and nevirapine in HIV-infected Ugandan adults. | PLoS One | 2008 |
| 18287207 | Substrate-dependent effects of human ABCB1 coding polymorphisms. | J Pharmacol Exp Ther | 2008 |
| 18364470 | The human multidrug resistance protein 4 (MRP4, ABCC4): functional analysis of a highly polymorphic gene. | J Pharmacol Exp Ther | 2008 |
| 17510066 | Interindividual variability in the effect of atazanavir and saquinavir on the expression of lymphocyte P-glycoprotein. | J Antimicrob Chemother | 2007 |
| 17259950 | ABCB1 pharmacogenetics: progress, pitfalls, and promise. | Clin Pharmacol Ther | 2007 |
| 16507877 | PharmGKB submission update: IV. PMT submissions of genetic variations in ATP-Binding cassette transporters to the PharmGKB network. | Pharmacol Rev | 2006 |
| 14706539 | A nonpeptide provides insight into mechanisms that regulate Drosophila melanogaster heart contractions. | Peptides | 2003 |